ENTITY
Épitalon
Épitalon
PulseAugur coverage of Épitalon — every cluster mentioning Épitalon across labs, papers, and developer communities, ranked by signal.
Total · 30d
0
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RECENT · PAGE 1/1 · 2 TOTAL
-
FDA faces decision on popular peptides amid safety and efficacy concerns
The FDA is facing a critical decision regarding the authorization of six popular but experimental peptides, which are increasingly being used for health, fitness, and longevity despite limited scientific evidence. Onlin…
-
FDA reviews popular peptides amid safety and efficacy concerns · 2 sources tracked
The U.S. Food and Drug Administration (FDA) is set to review seven peptides for potential approval for compounding by pharmacies. These peptides, including BPC-157, TB-500, and Semax, are popular in longevity and wellne…